New hope for Hard-to-Treat myeloma: experimental drug tested in chinese patients
NCT ID NCT06934044
First seen Oct 31, 2025 · Last updated Jun 18, 2026 · Updated 27 times
Summary
This early-stage study tests an experimental drug called cevostamab in about 20 Chinese adults whose multiple myeloma has returned or stopped responding to standard treatments. The main goals are to check the drug's safety, how the body processes it, and whether it can shrink tumors. Participants must be in fairly good health and have a life expectancy of at least 12 weeks.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE MYELOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Sun yat-sen University Cancer Center
RECRUITINGGuangzhou, Guangdong, 510555, China
-
The First Affiliated Hospital of Nanchang University
RECRUITINGNanchang, China
-
The First Affiliated Hospital of Wenzhou Medical University
RECRUITINGWenzhou, 325035, China
-
Tianjin Institute of Hematology & Blood Diseases Hospital
RECRUITINGTianjin, Tianjin Municipality, 301636, China
-
Tongji Hospital Tongji Medical College Huazhong University of Science and Technology
RECRUITINGWuhan, 430030, China
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.